Potential Applications of the Compact Fast-neutron Generator for the Adjuvant Treatment of Solid Tumours with the Intra-operative Radiotherapy (nIORT®) Technique: Simulation and Dosimetry Analyses with the MCNP Code

Authors

  • M. Sarotto Italian National Agency for New Technologies, Energy and Sustainable Economic Development, ENEA NUC-ENER-PRO, C.R. Saluggia, Strada per Crescentino 41 – 13040 Saluggia (ITALY)
  • M. Martellini TheranostiCentre S.r.l., Via Freguglia 8 – 20122 Milan (ITALY)
  • G. Ottaviano ENEA NUC-TNMT, C.R. Bologna, Via dei Mille Sole 21 – 40129 Bologna (ITALY)
  • G. Gherardi TheranostiCentre S.r.l., Via Freguglia 8 – 20122 Milan (ITALY)

DOI:

https://doi.org/10.14738/bjhr.1304.12052

Abstract

The potentiality of the intraoperative radiotherapy (IORT) with fast neutrons as an adjuvant treatment for severe solid cancers has been investigated in a 5-year research program. The therapeutic dose is administered by a single irradiation directly within the surgical cavity after surgical resection by means of a compact neutron generator (CNG) with the so-called neutron-IORT technique patented as nIORT®. Two CNG prototypes – exploiting the deuterium–deuterium fusion reaction to produce neutrons of 2.45 MeV energy - are currently undergoing experimental characterisation with the main objectives of demonstrating: - the therapeutic effectiveness of fast neutrons, having a relative biological effectiveness (RBE) ≈ 3÷4 times greater than that of standard RT treatments with X-rays and electrons, and low sensitivity to hypoxia; - the feasibility of installing the CNG - surrounded by ~1 m cube shield - in a hospital operating room dedicated to nIORT® treatments, without posing safety and environmental concerns. In parallel, several dosimetry analyses have been conducted using the MCNP Monte Carlo code by a detailed modelling of the CNG equipped with cylindrical and hemispherical nIORT® applicators positioned within brain and breast surgical cavities, respectively. Thanks to the high neutron flux (~10⁸ cm⁻² s⁻¹) and leveraging on the high RBE of fast neutrons, the MCNP simulations indicate that dose targets of ~10 Gy(RBE) could be administered in ~10÷20 minutes only. Moreover, the diffuse neutron beam may enable: the treatment of large and topographically irregular tumour beds, which remain challenging targets for the focused beams employed in standard RT and IORT techniques; the irradiation of the tumour bed margins - typically infiltrated by quiescent cancer cells and locale recurrences - thereby potentially enhancing the local tumour control; a limited damage and adverse effects to the nearest organs at risk, due to the limited penetration of neutrons over few centimetres in the biological tissues; to integrate the nIORT® adjuvant treatment for radioresistant tumours with local recurrences in a multimodal approach integrating surgery, chemotherapy and/or immunotherapy. In memory of Marina Gherardi, Marika de Feo and Gianluca Costamagna

References

ICRU report 16. Linear Energy Transfer. International Commission on radiation units and measurements, 1970; ISSN 0579-5435

Gordon K, Gulidov I, Fatkhudinov T, Koryakin S, Kaprin A. Fast and Furious: Fast Neutron Therapy in Cancer Treatment. International Journal of Particle Therapy, 2022; Volume 9, Issue 2, pp. 59-69. ISSN 2331-5180, https://doi.org/10.14338/IJPT-22-00017

Durante M. Proton beam therapy in Europe: more centres need more research, British Journal of Cancer 2019; 120, pp. 777-778. doi: 10.1038/s41416-018-0329-x

Suit H, DeLaney T, Goldberg S, Paganetti H, Clasie B, Gerweck L, Niemierko A, Hall E, Flanz J, Hallman J, Trofimov A. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol 2010 Apr; 95(1), pp. 3-22. doi: 10.1016/ j.radonc.2010.01.015

Jones DTL, Wambersie A. Radiation therapy with fast neutrons: a review. Nucl Instrum Meth Phys Res A 2007 Sept; 580(1), pp. 522-525. https://doi.org/10.1016/ j.nima.2007.05.220

Micke O, Schäfer U, Prott FJ, Schüller P, Scheuber M, Willich N. Fast neutron irradiation in advanced pre-irradiated head and neck tumors, Tumori 2000, Sept-Oct; 86(5), pp. 393-398. https://doi.org/10.1177/030089160008600505

Peters LJ, Maor MH, Laramore GE, Griffin TW, Hendrickson FR. Review of clinical results of fast neutron therapy in the USA. Strahlentherapie 1985 Dec; 161(12), pp. 731-738. PMID: 4082208

Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran SD, Bhrany AD, Hawes SE, Ladra M. Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck 2014; 36(8), pp. 1162-1167. doi: 10.1002/hed.23428

Mardynsky Y, Gulidov I, Aminov G, Ragulin Y, Kotuchov I, Gordon K. Reactor neutrons in multimodality treatment of locally advanced breast carcinoma. Adv Mater Res 2015; 1084, pp. 464-466 Scholar Publishing

Lukina E, Vazhenin AV, Kuznetsova AI, Mokichev GV, Munasipov ZZ, Bobko GG. Role of fast neutrons in the treatment of soft tissue sarcoma, Voprosy Onkologii 2010; 56(4), pp. 408-412

Rini F, Hall EJ, Marino SA. The Oxygen Enhancement Ratio as a Function of Neutron Energy with Mammalian Cells in Culture, Radiation Research 1979; 78(1), pp. 25-37. doi: 10.2307/3575004

Duncan W. An evaluation of the results of neutron therapy trials. Acta Oncol. 1994;33(3), pp. 299-306. doi: 10.3109/02841869409098421. PMID: 8018359.

Jones B. Clinical Radiobiology of Fast Neutron Therapy: What Was Learnt? Front. Oncol. Sec. Radiation Oncology 2020; Volume 10. doi: 10.3389/fonc.2020.01537

Mentana A, Quaresima V, Kundrát Pet al. Mapping neutron biological effectiveness for DNA damage induction as a function of incident energy and depth in a human sized phantom. Sci Rep 2025 Vol. 15, 2209. https://doi.org/10.1038/s41598-025-85879-2

Stelzer KJ, Douglas JG, Mankoff DA, Silbergeld DL, Krohn KA, Laramore GE, Spence AM. Positron emission tomography-guided conformal fast neutron therapy for glioblastoma multiforme. Neuro Oncol. 2008 Jan; 10 ( 1 ) , pp. 88 - 92 . doi: 10.1215/15228517-2007-044

Franco MS, Raulefs S, Schilling D, Combs SE, Schmid TE. Impact of Radiation on Invasion and Migration of Glioma In Vitro and In Vivo. Cancers (Basel) 2021; 16(23). doi: 10.3390/cancers16233900

Wank M, Schilling D, Reindl J et al. Evaluation of radiation-related invasion in primary patientderived glioma cells and validation with established cell lines: impact of different radiation qualities with differing LET. J Neurooncol. 2018;139, pp. 583–590. https://doi.org/10.1007/s11060-018-2923-4

Catterall M, Julian H, Bloom G, Ash DV, Walsh L, Richardson A, Uttley D, Noel Gowing FC, Lewis P, Chaucer B. Fast neutrons compared with megavoltage X-rays in the treatment of patients with supratentorial glioblastoma:a controlled pilot study. Int J Radiat Oncol Biol Phys. 1980;

Annals of the International Commission on Radiological Protection. ICRP 2007; 103(37). ISSN 0146-6453, ISBN 978-0-7020-3048-2

Stewart RD, Anderson A, Sandison G, Schwarz M, Grassberger C, Meyer J, Goff P, Laramore G, Liao J, Kim E, Parvathaneni U. O 05 - Comparative analysis of neutron relative biological effectiveness (RBE) for clinical, cellular and molecular endpoints. Int. J. of Particle Therapy 2024; Vol 11, Supplement, ISSN 2331-5180. https://doi.org/10.1016/ j.ijpt.2024.100028

Jones B. Fast neutron energy based modelling of biological effectiveness with implications for proton and ion beams. Phys. Med. Biol. 2021; 66 045028. doi: 10.1088/1361-6560/ abddd0

Karen K. Fu MD, Theodore MD, Phillips L, Jay R, Rowe MD. The RBE of neutrons in vivo. Cancer 1974 July; Vol 34 , Issue 1 , pp. 48 - 53 . https://doi.org/ 10.1002/1097-0142(197407)34:1<48::AID-CNCR2820340108>3.0.CO;2-Y

Méndez-Malagón C, Pedrosa-Rivera M, Ruiz-Magaña MJ, Porras I, Praena J, Oteo-Vives M, Méndez-Villafañe R, Fernández-Maza L, Sánchez-Doblado F, Fernández B, Macías M, Ruiz-Ruiz C. Comparison of the relative biological effectiveness of neutron irradiation of different energies on melanoma cells. Int J Radiat Biol. 2026;102(4):361-370. doi: 10.1080/09553002.2026.2618528.

Leung KN. New compact neutron generator system for multiple applications. Nuclear Tech. 2020; 206(10), pp. 1607-1614. doi: 10.1080/00295450.2020.1719800 Scholar Publishing

Dousset MH, Hamard J, Ricourt A. Distribution of the dose from neutrons in a thin sample of wet tissue as a function of linear energy transfer (LET). Phys. Med. Biol. 1971 Jul; 16(3), pp. 467-478. doi: 10.1088/0031-9155/16/3/008

LINCER project, Laboratorio per la caratterizzazione di Irradiatori Neutronici Compatti in Emilia Romagna 2020-2022. Funded by Emilia Romagna with “Legge Regionale 27/12/2018 N.25, DGR N. 545/2019 – CUP I74I19000360003”

Pelowitz B. MCNP6 user’s manual. Tech. Rep. Los Alamos National Lab 2013; LA-CP-13-00634 Rev. 0

Martellini M, Gherardi G. Apparatus for the intraoperative radiotherapy. European Patent 2019; EP 3 522 177 B1

Hashemi S. Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer. Int J Surg Oncol. 2021 Apr 16; 2476527. doi: 10.1155/2021/2476527

Hensley FW. Present State and Issues in IORT Physics. Radiat Oncol. 2017 Jan 27; 12(1):37. doi: 10.1186/s13014-016-0754-z

Cifarelli CP, Jacobson GM. Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors. Front. Oncol. Sec. Radiation Oncology 2021; 11. doi: 10.3389/fonc.2021.768168

Giordano FA, Abo-Madyan Y, Brehmer S, Herskind C, Sperk E, Schneider F, Clausen S, Welzel G, Schmiedek P, Wenz F. Intraoperative radiotherapy (IORT) - a resurrected option for treating glioblastoma? Translational Cancer Research 2014; 3(1). doi: 10.3978/ j.issn.2218-676X.2014.01.03

Kahl KH, Krauss PE, Neu M, Maurer CJ, Schill-Reiner S, Roushan Z, Laukmanis E, Dobner C, Janzen T, Balagiannis N, Sommer B, Stüben G, Shiban E. Intraoperative radiotherapy after neurosurgical resection of brain metastases as institutional standard treatment- update of the oncological outcome form a single center cohort after 117 procedures. J Neurooncol. 2024 Aug;169(1), pp. 187-193. doi: 10.1007/ s11060-024-04691-6

Usychkin S, Calvo S, Dos Santos MA, Samblás J, De Urbina DO, Bustos JC, Gutiérrez Diaz JA, Sallabanda K, Sanz A, Yélamos C, Peraza C, Delgado JM, Marsiglia H. Intra-Operative Electron Beam Radiotherapy for Newly Diagnosed and Recurrent Malignant Gliomas: Feasibility and Long-Term Outcomes. Clin Transl Oncol 2013; 15(1):33-8. doi: 10.1007/s12094-012-0892-1

Kiragga F, Brazovskiy K. Exploiting the unique interaction characteristics of fast neutrons for improved cancer therapy: A radiobiological perspective. Radiation Medicine and Protection 2024; Vol 5, Issue 1, pp. 24-29. ISSN 2666-5557. https://doi.org/10.1016/ j.radmp.2023.12.004

Gaillard F, Campos A, Kogan J, et al. Stupp protocol. Reference article, Radiopaedia.org Nov. 2024. https://doi.org/10.53347/rID-42300

Kexin Meng, Haijun Lu, Clinical application of high-LET radiotherapy combined with immunotherapy in malignant tumors, Prec Radiat Oncol. 2024; 8(1), pp. 42–46. https://doi.org/10.1002/pro6.1225

Martellini M, Gherardi G, Leung K, Leung JK, Sarotto M, Rizzo A. Multi Purpose Compact Apparatus for the Generation of a high-flux of neutrons, particularly for Intraoperative Radiotherapy. Int. Patent 2021, PCT/IT2021/000032. WIPO (World Intellectual Property Organisation) 2023, WO 2023/281539 A1

International Atomic Energy Agency (IAEA). Radiation Protection and Safety in Medical Uses of Ionizing Radiation. IAEA Safety Standards Series No. SSG-46, 2018. Scholar Publishing

Brown DA, et al. ENDF/B-VIII.0: The 8th Major Release of the Nuclear Reaction Data Library with CIELO-project Cross Sections, New Standards and Thermal Scattering Data. Nuclear Data Sheets 2018; Vol. 148, p. 1-142. doi: 10.1016/j.nds.2018.02.001

Cifarelli CP, Brehmer S, Vargo JA, Hack JD, Kahl KH, Sarria-Vargas G, Giordano FA. Intraoperative radiotherapy (IORT) for surgically resected brain metastases: outcome analysis of an international cooperative study. J Neurooncol. 2019 Nov;145(2), pp. 391-397. doi: 10.1007/s11060-019-03309-6

Martellini M, Sarotto M, Leung KN, Gherardi G, Rizzo A, Ottaviano G, Falzone L. Feasibility Study on the nIORT® Adjuvant Treatment of Glioblastoma Multiforme through the Irradiation Field of Fast Neutrons Produced by a Compact Generator. Medical Research Archives 2024; 12(2). doi: 10.18103/mra.v12i2.5090

Martellini M, Sarotto M, Leung KN, Gherardi G. A Compact Neutron Generator for the nIORT® Treatment of Severe Solid Cancers. Medical Research Archives 2023; 11(3). doi: 10.18103/mra.v 11i3.379

Martellini M, Sarotto M, Leung KN, Gherardi G, Falzone L. Feasibility Study on the nIORT® Adjuvant Treatment of Brain and Breast Cancers by Fast Neutrons produced by a DD-fusion Compact Generator. American Journal of Biomedical Science & Research 2024; 22(3). ISSN :2642-1747. doi: 10.34297/AJBSR.2024.22.002969

Martellini M, Sarotto M, Ferrari P, Gherardi G, Venturi M. Simulation of the nIORT® treatment by fast neutrons of severe brain cancers (as GBM) and comparison with standard IORT techniques adopting X-rays and electrons. Journal Cancer Science & Research 2025; Vol. 8, Issue 1. https://www.scivisionpub.com/pdfs/simulation-of-the-niort-treatment-by-fastneutrons-of-severe-brain-cancers-as-gbm-and-comparison-with-standard-iort-techniques-ado-3717.pdf

Barker CA, Postow MA. Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5), pp. 986-97. doi: 10.1016/j.ijrobp.2013.08.035

Müller M, Rösch L, Najafi S, Gatzweiler C, Ridinger J, Gerloff XF, Jones DTW, Baßler J, Kreth S, Stainczyk S, et al. Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma. Cancers. 2021; 13(17), 4476. https://doi.org/ 10.3390/cancers13174476

Michaeli O, Luz I, Vatarescu M, Manko T, Weizman N, Korotinsky Y, Tsitrina A, Braiman A, Arazi L, Cooks T. APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alphaparticles-based radiotherapy. Cell Death Dis. 2024 Jun 18;15(6):426. doi: 10.1038/s41419-024-06830-3

Chi A and Nguyen NP. Mechanistic rationales for combining immunotherapy with radiotherapy. Front. Immunol. 2023;14. doi: 10.3389/fimmu2023.1125905

Layer JP, Shiban E, Brehmer S, Diehl CD, Guedes de Castro D, Hamed M, Dejonckheere CS, Cifarelli DT, Friker LL, Herrlinger U, Hölzel M, Vatter H, Schneider M, Combs S E, Schmeel LC, Cifarelli CP, Giordano FA, Sarria GR, Kahl KH. Multicentric assessment of safety and efficacy of combinatorial adjuvant brain metastasis treatment by intraoperative radiotherapy and immunotherapy, Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1552-1562. https://doi.org/10.1016/j.ijrobp.2024.01.009

Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A. Multiple resections for patients with glioblastoma: prolonging survival. J Neurosurg. 2012 Oct 19;118(4), pp.812-820. doi: 10.3171/2012.9.JNS1277

Downloads

Published

2026-08-06

How to Cite

Sarotto, M., Martellini, M., Ottaviano, G., & Gherardi, G. (2026). Potential Applications of the Compact Fast-neutron Generator for the Adjuvant Treatment of Solid Tumours with the Intra-operative Radiotherapy (nIORT®) Technique: Simulation and Dosimetry Analyses with the MCNP Code . British Journal of Healthcare and Medical Research, 13(04), 256–274. https://doi.org/10.14738/bjhr.1304.12052